Mitotherapeutix's Debt - II Round

Mitotherapeutix raised a round of funding on December 28, 2017.

Mitotherapeutix is a biotechnology drug discovery company focused on cancer and liver disease.…

Articles about Mitotherapeutix's Debt - II Round: